• EN
    • SV
  • About Us
    • Saniona
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Science overview
    • Ion channels
    • Publications & posters
    • Partnerships & spinouts
    • The discovery process
  • Our Programs
    • Pipeline overview
    • SAN2668
    • SAN2465
    • SAN2219
    • SAN903
    • Tesofensine
    • Tesomet
    • The development process
  • Patients & Caregivers
    • Indication overview
    • Epilepsy
    • Major depressive disorder
    • Rare diseases
    • Hypothalamic obesity
    • Prader-Willi syndrome
  • Investor Relations
    • Investors overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Latest news
    • Press Releases
    • Interviews
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
  • EN
  • SV
INVESTORS

Events and
Presentations

Saniona Icon blue
  • Overview
  • The Share
    • Share Information
    • Ownership Structure
  • Financial Calendar
  • Reports & Fillings
    • Annual & Quarterly Reports
    • Prospectus
    • Old prospectus
  • Analysts
  • Events and Presentations
  • FAQs
  • Corporate governance
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Shareholder Meetings
    • Nomination Committee
    • Auditors
    • Remuneration Incentive Programs

Corporate Presentation

Corporate Presentation (May 2026)

Upcoming Events

Affärsvärlden Börsdagarna (Stockholm)
September 15, 2026 - September 15, 2026
BIO-Europe Fall 2026 (Cologne)
November 9, 2026 - November 11, 2026

Past Events

Aktieinfo – Investor meeting – Kolding (DK)
November 25, 2025 - November 25, 2025
Aktieinfo – Investor meeting – Aalborg (DK)
November 24, 2025 - November 24, 2025
Affärsvärlden Growth Companies Event – Stockholm
November 18, 2025 - November 18, 2025
Dansk Aktionærforening – InvestorDagen – Copenhagen
November 17, 2025 - November 17, 2025
Biostock – Life Science Summit – Lund
November 12, 2025 - November 13, 2025
BIO-Europe – Vienna
November 3, 2025 - November 5, 2025
Redeye – Neurology event – Stockholm
October 15, 2025 - October 15, 2025
Redeye
Økonomisk Ugebrev – Investor Conference – Copenhagen
September 24, 2025 - September 24, 2025
Pareto Securities – 16th Annual Health Conference – Stockholm
September 16, 2025 - September 16, 2025
Saniona Q2 investor call
August 28, 2025
Presentation
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • Next »
  • About Us
    • Saniona
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Science overview
    • Ion channels
    • Publications & posters
    • Partnerships & spinouts
    • The discovery process
  • Our Programs
    • Pipeline overview
    • SAN2668
    • SAN2465
    • SAN2219
    • SAN903
    • Tesofensine
    • Tesomet
    • The development process
  • Patients & Caregivers
    • Indication overview
    • Epilepsy
    • Major depressive disorder
    • Rare diseases
    • Hypothalamic obesity
    • Prader-Willi syndrome
  • Investor Relations
    • Investors overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Latest news
    • Press Releases
    • Interviews
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
DENMARK

Murervangen 42
DK-2600 Glostrup
Denmark
+45 7070 5225
saniona@saniona.com

CONNECT 
  • Follow
  • Follow
  • Follow

© 2026 Saniona. All rights reserved.

Privacy Policy